Why is ANG Lifesciences falling/rising?

As of 08-Jul, ANG Lifesciences India Ltd is experiencing a price increase, currently at 34.60, which reflects a rise of 0.79 or 2.34%. The stock has shown strong performance recently, gaining 18.45% over the last four days and outperforming its sector by 3.27%. However, despite this short-term positive movement, the company has significant underlying issues, including operating losses and a high Debt to EBITDA ratio of 5.83 times, which indicates a weak long-term fundamental strength. The company has reported negative results for the last 12 consecutive quarters, with net sales falling by 55.55% and a negative return on equity, contributing to its risky profile and potential for further declines.
In the broader market context, the stock's recent performance stands in stark contrast to its long-term returns, having generated a -32.82% return over the past year while the benchmark Sensex has increased by 4.69%. This consistent underperformance against the benchmark over the last three years, coupled with 44.88% of promoter shares being pledged, adds downward pressure on the stock. Although the stock has shown short-term gains, the overall market sentiment remains cautious due to the company's ongoing financial struggles and negative EBITDA, which could hinder its ability to sustain this upward momentum.